Vineti and Quick Specialized Healthcare Logistics Deliver Tips For Cell And Gene Therapy Success

Creative Commons License Source: Gerd Altmann, no changes made.
Advertisement

Vineti, Inc and Quick Specialized Healthcare Logistics have partnered to help biopharma innovators of cell and gene therapies by releasing a new tip sheet focused on industry-proven best practices.

Vineti, headquartered in San Francisco, California, USA, is the first commercial, configurable, cloud-based software platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE Ventures and the Mayo Clinic in 2016 to solve the key challenges patients, medical providers, biopharmaceutical companies and regulators face in the delivery and commercialization of individualized therapies.

The Vineti “platform of record” integrates logistics, manufacturing and clinical data for individualized therapies to align and orchestrate the cell and gene therapy process and improve product performance overall.

Caregivers and pharmaceutical pioneers are empowered to help more patients more effectively and safely, treatments are better understood and improved over time, and most importantly, there’s an opportunity to provide greater health outcomes and cures to patients in need. The company is growing rapidly, and the Vineti platform is now in use world-wide.

The Quick Group, headquartered in New York, USA, has a global footprint, serving the life science and healthcare community since 1981, providing 24/7 customized logistics and transportation solutions for time-and temperature-sensitive, mission-critical and life-saving needs.

As the trusted logistics leader, Quick safely and quickly transports personalized medicine, human organs and tissue for transplant or research, blood, blood products, cord blood, bone marrow, medical devices and equipment, operating from their CGT Center of Excellence locations in Chicago, USA and London, UK.

The new tip sheet covers everything from cell and gene therapy’s (CGT) need for continuous collaboration to appropriate packaging and transportation routing strategies.

Authored by David Murphy (Quick) and Heidi Hagen (Vineti), Cell and Gene Therapies: Eight Tips to Strengthen Your Supply Chain offers valuable advice from industry veterans who were among the first to provide operations, logistics, and supply chain support for personalized medicine therapies. Together, the authors have more than 35 years of combined industry experience that can help support this rapidly developing field.

“Vineti’s expert team is asked to advise the cell and gene therapy industry every day, and we’re always happy to help.” … “The deeply experienced team at Quick has also done pioneering work in cell and gene therapy, and we know from our shared integrations that Quick’s leadership helps keep the industry moving. We’ve very pleased to have this chance to partner with Quick to share some of our collective knowledge.” – Amy DuRoss, CEO and co-founder of Vineti

“Quick is honored to serve the biopharma industry and provide logistics support for these promising personalized medicine therapies,” … “The CGT supply chain is complex and requires sophisticated technology platforms to synchronize the entire process.  We are excited to be partnering with Vineti, digital innovation experts, and offer a proven solution that automates, integrates, and tracks the entire supply chain, helping to ensure patient success.” – David Murphy, Executive VP of Quick Life Science

Sources:

  1. https://www.prnewswire.com/news-releases/vineti-and-quick-specialized-healthcare-logistics-partner-to-share-industry-expertise-that-helps-strengthen-cell-and-gene-therapy-supply-chains-300749932.html
  2. https://www.crunchbase.com/organization/vineti#section-overview
  3. https://www.genewsroom.com/press-releases/ge-ventures-and-mayo-clinic-launch-company-scale-and-digitize-cell-and-gene-therapies
  4. https://www.linkedin.com/company/quickhealthcare/about/
Advertisement

David is a consultant/medical writer for a number of ongoing healthcare initiatives including for Athla LLC/ HealthLabs, a discovery automation company for Big Data leveraging Big Compute. He has a number of years experience in academic R&D and healthcare related projects including the fields of oncology and immunotherapy.